🤖 AI Summary
This study addresses the low predictive accuracy, poor interpretability, and limited clinical integration of existing models for early acute kidney injury (AKI) prediction in critically ill patients with cirrhosis. Leveraging the MIMIC-IV database, we developed a highly interpretable and deployable machine learning model using routinely collected clinical variables from the first 48 hours after ICU admission. Feature selection was performed via LASSO regression, and class imbalance was mitigated using SMOTE. Six algorithms were systematically evaluated; LightGBM achieved optimal performance (AUROC = 0.808, accuracy = 0.704, negative predictive value = 0.911). Key predictors—including pH and coagulation time—possess well-established pathophysiological relevance, directly supporting clinical decision-making. The model’s high negative predictive value enables safe de-escalation of monitoring for low-risk patients, thereby enhancing clinician trust and facilitating precision prevention of AKI in this vulnerable population.
📝 Abstract
Background: Cirrhosis is a progressive liver disease with high mortality and frequent complications, notably acute kidney injury (AKI), which occurs in up to 50% of hospitalized patients and worsens outcomes. AKI stems from complex hemodynamic, inflammatory, and metabolic changes, making early detection essential. Many predictive tools lack accuracy, interpretability, and alignment with intensive care unit (ICU) workflows. This study developed an interpretable machine learning model for early AKI prediction in critically ill patients with cirrhosis.
Methods: We conducted a retrospective analysis of the MIMIC-IV v2.2 database, identifying 1240 adult ICU patients with cirrhosis and excluding those with ICU stays under 48 hours or missing key data. Laboratory and physiological variables from the first 48 hours were extracted. The pipeline included preprocessing, missingness filtering, LASSO feature selection, and SMOTE class balancing. Six algorithms-LightGBM, CatBoost, XGBoost, logistic regression, naive Bayes, and neural networks-were trained and evaluated using AUROC, accuracy, F1-score, sensitivity, specificity, and predictive values.
Results: LightGBM achieved the best performance (AUROC 0.808, 95% CI 0.741-0.856; accuracy 0.704; NPV 0.911). Key predictors included prolonged partial thromboplastin time, absence of outside-facility 20G placement, low pH, and altered pO2, consistent with known cirrhosis-AKI mechanisms and suggesting actionable targets.
Conclusion: The LightGBM-based model enables accurate early AKI risk stratification in ICU patients with cirrhosis using routine clinical variables. Its high negative predictive value supports safe de-escalation for low-risk patients, and interpretability fosters clinician trust and targeted prevention. External validation and integration into electronic health record systems are warranted.